J. Lipid Res.  Neurobiology of Lipids (ISSN1683-5506)
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on September 1, 2005

Papers In Press, published online ahead of print July 1, 2005
J. Lipid Res., doi:10.1194/jlr.M500067-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
M500067-JLR200v1
46/9/1823    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tovar, A. R.
Right arrow Articles by Torres, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tovar, A. R.
Right arrow Articles by Torres, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on February 18, 2005
Revised on June 14, 2005
Accepted on June 24, 2005

Soy protein reduces hepatic lipotoxicity in hyperinsulinemic obese Zucker fa/fa rats

Armando R. Tovar, Ivan Torre-Villalvazo, Melissa Ochoa, Ana L. Elias, Victor Ortiz, Carlos A. Aguilar-Salinas, and Nimbe Torres

Physiology of Nutrition, Instituto Nacional de Ciencias Medicas y Nutricion SZ, Mexico, DF 14000

Corresponding Author: nimbet{at}quetzal.innsz.mx

Hepatic steatosis is commonly present during the development of insulin resistance, and it is a clear sign of lipotoxicity due in part to an accelerated lipogenesis. There is evidence that soy protein diet prevents the overexpression of hepatic SREBP-1 decreasing lipid accumulation. Therefore the aim of the present work was to study whether a soy protein diet may prevent the development of fatty liver through the regulation of transcription factors involved in lipid metabolism in hyperinsulinemic and hyperleptinemic Zucker obese fa/fa rats. Serum and hepatic cholesterol (C) and triglyceride (T) levels, as well as VLDL-T and LDL-C were significantly lower in rats fed soy protein than rats a fed casein diet for 160 days. The reduction in hepatic cholesterol was associated with a low expression of LXR-a and its target genes: CYP7A1 and ABCA1. Soy protein also decreased the expression of SREBP-1 as well as several of its target genes FAS, SCD-1, 5 and 6 desaturases, decreasing lipogenesis even in the presence of hyperinsulinemia. Reduction in SREBP-1 was not associated with the presence of soy isoflavones. Finally, soy protein reduced SREBP-1 expression in adipocytes preventing hypertrophy, which also contribute to prevent the development of hepatic lipotoxicity.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
J. Trujillo, C. Cruz, A. Tovar, V. Vaidya, E. Zambrano, J. V. Bonventre, G. Gamba, N. Torres, and N. A. Bobadilla
Renoprotective mechanisms of soy protein intake in the obese Zucker rat
Am J Physiol Renal Physiol, November 1, 2008; 295(5): F1574 - F1582.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. Hageman, C. Severijnen, B. J. M. van de Heijning, H. Bouritius, N. van Wijk, K. van Laere, and E. M. van der Beek
A Specific Blend of Intact Protein Rich in Aspartate Has Strong Postprandial Glucose Attenuating Properties in Rats
J. Nutr., September 1, 2008; 138(9): 1634 - 1640.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. A Thorp, P. R. Howe, T. A Mori, A. M Coates, J. D Buckley, J. Hodgson, J. Mansour, and B. J Meyer
Soy food consumption does not lower LDL cholesterol in either equol or nonequol producers
Am. J. Clinical Nutrition, August 1, 2008; 88(2): 298 - 304.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
I. Torre-Villalvazo, A. R. Tovar, V. E. Ramos-Barragan, M. A. Cerbon-Cervantes, and N. Torres
Soy Protein Ameliorates Metabolic Abnormalities in Liver and Adipose Tissue of Rats Fed a High Fat Diet
J. Nutr., March 1, 2008; 138(3): 462 - 468.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
M. C. Cave, R. T. Hurt, T. H. Frazier, P. J. Matheson, R. N. Garrison, C. J. McClain, and S. A. McClave
Obesity, Inflammation, and the Potential Application of Pharmaconutrition
Nutr Clin Pract, February 1, 2008; 23(1): 16 - 34.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
G. K. Maiyoh, J. E. Kuh, A. Casaschi, and A. G. Theriault
Cruciferous Indole-3-Carbinol Inhibits Apolipoprotein B Secretion in HepG2 Cells
J. Nutr., October 1, 2007; 137(10): 2185 - 2189.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Noriega-Lopez, A. R. Tovar, M. Gonzalez-Granillo, R. Hernandez-Pando, B. Escalante, P. Santillan-Doherty, and N. Torres
Pancreatic Insulin Secretion in Rats Fed a Soy Protein High Fat Diet Depends on the Interaction between the Amino Acid Pattern and Isoflavones
J. Biol. Chem., July 13, 2007; 282(28): 20657 - 20666.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.